Use of association studies to define genetic modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Familial Cancer

• Publication date

  2008-02-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10689-008-9181-0PMID 18283561
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies.

  2007cited by this paper
• A common coding variant in CASP8 is associated with breast cancer risk

  2007cited by this paper
• Methyl group metabolism gene polymorphisms as modifier of breast cancer risk in Italian BRCA1/2 carriers

  2007cited by this paper
• AURKA F31I Polymorphism and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Consortium of Investigators of Modifiers of BRCA1/2 Study

  2007cited by this paper
• The RAD51 135 G>C Polymorphism Modifies Breast Cancer and Ovarian Cancer Risk in Polish BRCA1 Mutation Carriers

  2007influential reference
• The Prevalence of BRCA2 Mutations in Familial Pancreatic Cancer

  2007cited by this paper
• An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA)

  2007influential reference
• Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers.

  2006cited by this paper
• Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS).

  2006cited by this paper
• Does nonsense-mediated mRNA decay explain the ovarian cancer cluster region of the BRCA2 gene?

  2006cited by this paper
• Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group.

  2006influential reference
• A haplotype containing the p53 polymorphisms Ins16bp and Arg72Pro modifies cancer risk in BRCA2 mutation carriers

  2006cited by this paper
• The AIB1 Polyglutamine Repeat Does Not Modify Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

  2006cited by this paper
• Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 gene

  2005cited by this paper
• Biallelic BRCA2 mutations are associated with multiple malignancies in childhood including familial Wilms tumour

  2005cited by this paper
• Prediction of BRCA1 Status in Patients with Breast Cancer Using Estrogen Receptor and Basal Phenotype

  2005cited by this paper
• Polyglutamine repeat length in the NCOA3 does not affect risk in familial breast cancer.

  2005cited by this paper
• A weighted cohort approach for analysing factors modifying disease risks in carriers of high‐risk susceptibility genes

  2005cited by this paper
• The BRCA2 homologue Brh2 nucleates RAD51 filament formation at a dsDNA–ssDNA junction

  2005cited by this paper
• Common BRCA2 variants and modification of breast and ovarian cancer risk in BRCA1 mutation carriers.

  2005influential reference
• Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations

  2005cited by this paper
• Common variation in BRCA2 and breast cancer risk: a haplotype-based analysis in the Multiethnic Cohort.

  2004cited by this paper
• Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes

  2004cited by this paper
• The future of association studies: gene-based analysis and replication.

  2004cited by this paper
• Epidemiology of breast cancer among BRCA mutation carriers: an overview.

  2004cited by this paper
• Polyglutamine repeat length in the AIB1 gene modifies breast cancer susceptibility in BRCA1 carriers

  2004influential reference
• A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers

  2004cited by this paper
• Prevalence of BRCA1 mutation carriers among U.S. non-Hispanic Whites.

  2004cited by this paper
• Emerging functions of BRCA2 in DNA recombination.

  2004cited by this paper
• The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers

  2004cited by this paper
• Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation

  2003cited by this paper
• Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in Poland.

  2003cited by this paper
• BRCA2 arg372hispolymorphism and epithelial ovarian cancer risk

  2003influential reference
• Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia.

  2003cited by this paper
• BRCA1 wild-type allele modifies risk of ovarian cancer in carriers of BRCA1 germ-line mutations.

  2003cited by this paper
• The genetics and genomics of cancer

  2003cited by this paper
• Efficient selective screening of haplotype tag SNPs

  2003cited by this paper
• Choosing Haplotype-Tagging SNPS Based on Unphased Genotype Data Using a Preliminary Sample of Unrelated Subjects with an Example from the Multiethnic Cohort Study

  2003cited by this paper
• Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

  2003cited by this paper
• Association of BRCA2 polymorphism at codon 784 (Met/Val) with breast cancer risk and prognosis.

  2003cited by this paper
• Review Cancer Susceptibility and the Functions of BRCA1 and BRCA2

  2002cited by this paper
• A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes

  2002cited by this paper
• Inherited predisposition and breast cancer: Modifiers of BRCA1/2‐associated breast cancer risk

  2002cited by this paper
• Biallelic Inactivation of BRCA2 in Fanconi Anemia

  2002cited by this paper
• Variation in BRCA1 cancer risks by mutation position.

  2002cited by this paper
• The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codons.

  2002cited by this paper
• Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program.

  2002cited by this paper
• Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotype

  2002cited by this paper
• A single mutated BRCA1 allele leads to impaired fidelity of double strand break end-joining

  2002cited by this paper
• Evidence of haplotype insufficiency in human cells containing a germline mutation in BRCA1 or BRCA2

  2002cited by this paper
• Variants in DNA double-strand break repair genes and breast cancer susceptibility.

  2002cited by this paper
• Heritability of mammographic density, a risk factor for breast cancer.

  2002cited by this paper
• The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years.

  2002cited by this paper
• CGH-targeted linkage analysis reveals a possible BRCA1 modifier locus on chromosome 5q.

  2002cited by this paper
• The relationship between the roles of BRCA genes in DNA repair and cancer predisposition.

  2002cited by this paper
• Modifiers of risk of hereditary breast and ovarian cancer

  2002cited by this paper
• Cancer susceptibility and the functions of BRCA1 and BRCA2.

  2002cited by this paper
• A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers

  2001influential reference
• CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers

  2001cited by this paper
• Variation in cancer risks, by mutation position, in BRCA2 mutation carriers.

  2001cited by this paper
• Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history.

  2001cited by this paper
• "Other" breast cancer susceptibility genes: searching for more holy grail.

  2001cited by this paper
• A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers.

  2001cited by this paper
• Ovarian cancer, oral contraceptives, and BRCA mutations.

  2001cited by this paper
• Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor.

  2000cited by this paper
• A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability

  2000cited by this paper
• BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures.

  2000cited by this paper
• Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families.

  2000cited by this paper
• Lessons learned from BRCA1 and BRCA2

  2000cited by this paper
• Polymorphic repeat in AIB1 does not alter breast cancer risk

  2000cited by this paper
• Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2

  1999cited by this paper
• Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.

  1999cited by this paper
• Cancer risks in BRCA2 mutation carriers.

  1999cited by this paper
• Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat.

  1999influential reference
• Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2.

  1999cited by this paper
• Germline BRCA1 alterations in a population-based series of ovarian cancer cases.

  1999cited by this paper
• The AF1 and AF2 Domains of the Androgen Receptor Interact with Distinct Regions of SRC1

  1999cited by this paper
• Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

  1998cited by this paper
• Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer.

  1998cited by this paper
• Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women.

  1998cited by this paper
• In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity.

  1998cited by this paper
• Polymorphic exonic CAG microsatellites in the gene amplified in breast cancer (AIB1 gene)

  1998cited by this paper
• Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study.

  1998cited by this paper
• Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.

  1998cited by this paper
• Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation

  1997cited by this paper
• Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.

  1997cited by this paper
• AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer.

  1997cited by this paper
• Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population.

  1997cited by this paper
• Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor.

  1997cited by this paper
• Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene

  1997cited by this paper
• Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos.

  1997cited by this paper
• The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds

  1996cited by this paper
• Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations.

  1996cited by this paper
• Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities

  1996cited by this paper
• Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study.

  1996cited by this paper
• Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2

  1996cited by this paper
• Identification of the breast cancer susceptibility gene BRCA2

  1995cited by this paper
• Risk modifiers in carriers of brca1 mutations

  1995cited by this paper
• Unusual case of Smith-Lemli-Opitz syndrome "type II".

  1995cited by this paper
• Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

  1995cited by this paper

• A New Inverse Probability of Selection Weighted Cox Model to Deal With Outcome‐Dependent Sampling in Survival Analysis

  2023cites this paper
• Investigation of The Relationship of TNFRSF11A Gene Polymorphisms with Breast Cancer Development and Metastasis Risk in Patients with BRCA1 Or BRCA2 Pathogenic Variants Living in The Trakya Region of Turkey

  2020cites this paper
• Breast Cancer Genetics

  2017cites this paper
• On hereditary ovarian cancer: Towards improved management of BRCA1/2 mutation carriers in opposite sides of the world

  2017cites this paper
• Gene Set Enrichment and Projection: A Computational Tool for Knowledge Discovery in Transcriptomes

  2016cites this paper
• phylogenetic approach identified mitochondrial haplogroup T 1 a 1 as inversely associated with breast cancer risk in BRCA 2 mutation carriers

  2015cites this paper
• An original phylogenetic approach identifiedmitochondrial haplogroup T1a1 as inverselyassociated with breast cancer risk in BRCA2mutation carriers

  2015cites this paper
• An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

  2015cites this paper
• Association between the RAD51 135 G>C Polymorphism and Risk of Cancer: A Meta-Analysis of 19,068 Cases and 22,630 Controls

  2013cites this paper
• Mutational analysis of brca 2 gene for SNPdetection responsible for Breast cancer

  2013cites this paper
• Genetic Determinants of Breast Cancer Risk: A Review of Current Literature and Issues Pertaining to Clinical Application

  2012cites this paper
• Mutations and polymorphic BRCA variants transmission in breast cancer familial members

  2011cites this paper
• Mutations and polymorphic BRCA variants transmission in breast cancer familial members

  2011cites this paper
• The AIB1 gene polyglutamine repeat length polymorphism and the risk of breast cancer development

  2010cites this paper
• Genetic and epigenetic changes in malignant cells of tumors of urogenital organs

  2010cites this paper
• RAD51 135G>C polymorphism and breast cancer risk: a meta-analysis

  2010cites this paper
• Breast Cancer in the Personal Genomics Era

  2010cites this paper
• Utilizing Saccharomyces cerevisiae to identify aneuploidy and cancer susceptibility genes.

  2010cites this paper
• The role of BACH1 , BARD1 and TOPBP1 genes in familial breast cancer

  2009cites this paper
• Update on genetic predisposition to breast cancer

  2009cites this paper
• Polymorphisms in BRCA2 resulting in aberrant codon-usage and their analysis on familial breast cancer risk

  2009cites this paper
• ¿Sabemos qué causa el cáncer de mama? Influencia actual de los diferentes factores de riesgo

  2009cites this paper